Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / COM
-
Number of holders
-
161
-
Total 13F shares, excl. options
-
42,106,165
-
Shares change
-
+6,136,650
-
Total reported value, excl. options
-
$212,715,890
-
Value change
-
+$30,515,138
-
Put/Call ratio
-
170%
-
Number of buys
-
86
-
Number of sells
-
63
-
Price
-
$5.05
Institutional Holders of Humacyte, Inc. - COM (HUMA) as of Q4 2024
As of 31 Dec 2024 Humacyte, Inc. - COM (HUMA) had 197 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 42,106,165 shares of stock of the company.
Largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, STATE STREET CORP, Woodline Partners LP, GEODE CAPITAL MANAGEMENT, LLC, CenterBook Partners LP, UBS Group AG, TWO SIGMA INVESTMENTS, LP, MILLENNIUM MANAGEMENT LLC, and NORTHERN TRUST CORP.
This table shows 197 institutional shareholders of the security as of 31 Dec 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.